http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103087026-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7826e82a59639f553bfb024dfb2a0ea5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate | 2008-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd43211214d212660a264a52dea07bc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3cf98da98339f659742b99564bc9041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f43e61a6158a41fe92549ee82d92dd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2661dfb050bb059f1a050d1f946f481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_788128902976c2ee565d0a1018572663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c182627d0b25fafbf2e8cd5a59e45ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c73253f3d62de1446f946b539a520c2 |
| publicationDate | 2015-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103087026-B |
| titleOfInvention | Crystal form D of 7-hydroxyl isoflavone, preparation method of crystal form D and medicine composition and use of crystal form D |
| abstract | The invention discloses five crystal forms of 7- hydroxyl isoflavone, preparation methods of crystal forms and medicine compositions and uses of crystal forms. Specifically, the invention relates to the crystal form A, the crystal form B, the crystal form C, the crystal form D and the crystal form E, which exist under a solid state, of the 7-hydroxyl isoflavone, relates to the preparation methods for preparing the samples of the five crystal forms, relates to various preparations which are prepared and developed by using different crystal form substances of the 7-hydroxyl isoflavone as active ingredients, as well as the dominant clinical treatment action of the medicine compositions of the preparations in preventing cardiovascular and cerebrovascular diseases, osteoporosis, inflammation, metabolic diseases and other diseases. The crystal forms can be used for affecting the absorption rate of the solid medicine active ingredients in the living body, and reinforcing or reducing the plasma drug concentration in the living body, thereby affecting the clinical treatment action of the medicines. |
| priorityDate | 2008-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.